Biologics R&D: select news

Cardiac monitoring safety assessment framework for early phase group a streptococcal vaccine trials

https://pubmed.ncbi.nlm.nih.gov/40450801/

jeanfrancoismaison

Jun 21 min read

Sample size efficiency of restricting participation in tuberculosis vaccine trials to interferon-gamma release assay-positive participants

https://pubmed.ncbi.nlm.nih.gov/40450848/

jeanfrancoismaison

Jun 21 min read

Distal airway epithelial progenitors mediate TGF-β release to drive lung CD8+ TRM induction following mucosal BCG vaccination

https://pubmed.ncbi.nlm.nih.gov/40451435/

jeanfrancoismaison

Jun 21 min read

Serum factors create species-specific barriers to hepatic gene transfer by lipid nanoparticles in liver-humanized mice

https://pubmed.ncbi.nlm.nih.gov/40454419/

jeanfrancoismaison

Jun 21 min read

Neuromethods: Basic Techniques for Evaluating the Nervous System in Nonclinical Studies

https://pubmed.ncbi.nlm.nih.gov/40448975/

jeanfrancoismaison

Jun 11 min read

Targeting CD8+ T cells in cardiovascular diseases - current options and therapeutic perspectives

https://pubmed.ncbi.nlm.nih.gov/40448685/

jeanfrancoismaison

Jun 11 min read

Advancements in RNA-Targeted Therapies for Renal Cell Carcinoma

https://pubmed.ncbi.nlm.nih.gov/40449649/

jeanfrancoismaison

Jun 11 min read

Peripheral blood CD4+ and CD8+ T cell responses to Cryptococcus candidate vaccine antigens in human subjects with and without cryptococcosis

https://pubmed.ncbi.nlm.nih.gov/40449806/

jeanfrancoismaison

Jun 11 min read

Plasmid DNA and mRNA delivery: Approaches and challenges

https://pubmed.ncbi.nlm.nih.gov/40449975/

jeanfrancoismaison

Jun 11 min read

Immunological biomarkers of aging

https://pubmed.ncbi.nlm.nih.gov/40443365/

jeanfrancoismaison

May 311 min read

Assessing the fitness of Epstein-Barr virus following its reactivation

https://pubmed.ncbi.nlm.nih.gov/40444990/

jeanfrancoismaison

May 311 min read

Chemokine (C-X-C motif) ligand 11 is a crucial antiviral modulator that affects viral replication, the IFN-γ response, and T-cell functions during respiratory syncytial virus infection

https://pubmed.ncbi.nlm.nih.gov/40447278/

jeanfrancoismaison

May 311 min read

Ultrapotent SARS coronavirus-neutralizing single-domain antibodies that clamp the spike at its base

https://pubmed.ncbi.nlm.nih.gov/40447603/

jeanfrancoismaison

May 311 min read

Single dose VSV-based vaccine protects mice against lethal heterologous Crimean-Congo hemorrhagic fever virus challenge

https://pubmed.ncbi.nlm.nih.gov/40447644/

jeanfrancoismaison

May 311 min read

Preclinical Safety

https://pubmed.ncbi.nlm.nih.gov/40445826/

jeanfrancoismaison

May 311 min read

Potential of Circular RNAs (circRNAs) Neoantigen Vaccines in Tumor Immunotherapy

https://pubmed.ncbi.nlm.nih.gov/40442904/

jeanfrancoismaison

May 311 min read

The Development of a Preclinical Swine Model for Endometriosis

https://pubmed.ncbi.nlm.nih.gov/40445172/

jeanfrancoismaison

May 311 min read

The VP5 protein of the oncolytic virus OH2 regulates nectin-3 molecule to modulate tumor cell apoptosis

https://pubmed.ncbi.nlm.nih.gov/40446441/

jeanfrancoismaison

May 311 min read

Neovascular pruning by IDO1 inhibitors can potentiate immunogenic cytotoxicity of ischemia-targeted agents to synergistically enhance anti-PD-1 responsiveness

https://pubmed.ncbi.nlm.nih.gov/40447318/

jeanfrancoismaison

May 311 min read

From precision interventions to precision health

https://pubmed.ncbi.nlm.nih.gov/40447582/

jeanfrancoismaison

May 311 min read